Management of metastatic bone disease (MBD)

被引：2
|
作者：
Trompeter, Alex [1 ]
机构：
[1] British Orthopaed Assoc Trauma Comm, London, England
来源：
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED | 2022年 / 53卷 / 12期
关键词：
CANCER; FEMUR;
D O I：
10.1016/j.injury.2022.09.054
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：3869 / 3871
页数：3
相关论文
共 50 条
  • [21] THE SURGICAL-MANAGEMENT OF METASTATIC BONE-DISEASE
    CROMACK, PI
    DWYER, AP
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1980, 62 (02): : 263 - 263
  • [22] What’s new in the management of metastatic bone disease
    Shinji Tsukamoto
    Costantino Errani
    Akira Kido
    Andreas F. Mavrogenis
    European Journal of Orthopaedic Surgery & Traumatology, 2021, 31 : 1547 - 1555
  • [23] Management of metastatic bone disease of the pelvis: current concepts
    Cevik, Huseyin Bilgehan
    Ruggieri, Pietro
    Giannoudis, Peter V.
    EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2023, 50 (4) : 1277 - 1294
  • [24] MANAGEMENT OF MALIGNANT DISEASE METASTATIC TO BONE BY HORMONAL ALTERATIONS
    MELLETTE, SJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1970, (73) : 73 - &
  • [25] Meta-analysis of effects of zoledronic acid (ZOL) on survival in patients with metastatic bone disease (MBD) and high bone turnover
    Coleman, Robert
    Cook, Richard
    Saad, Fred
    Hirsh, Vera
    Major, Pierre
    Dias, Rosh
    Lipton, Allan
    CANCER TREATMENT REVIEWS, 2008, 34 : S86 - S86
  • [26] The Role of Bone Biopsy in the Management of CKD-MBD
    Ferreira, Ana Carina
    Cohen-Solal, Martine
    D'Haese, Patrick C.
    Ferreira, Anibal
    CALCIFIED TISSUE INTERNATIONAL, 2021, 108 (04) : 528 - 538
  • [27] The Role of Bone Biopsy in the Management of CKD-MBD
    Ana Carina Ferreira
    Martine Cohen-Solal
    Patrick C. D’Haese
    Aníbal Ferreira
    Calcified Tissue International, 2021, 108 : 528 - 538
  • [28] Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD): Survival in patients with high bone turnover
    Cook, R. J.
    Hirsh, V.
    Major, P. P.
    Saad, F.
    Dias, R.
    Lipton, A.
    Coleman, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] The use of molecular markers of bone turnover in the management of patients with metastatic bone disease
    Seibel, Markus J.
    CLINICAL ENDOCRINOLOGY, 2008, 68 (06) : 839 - 849
  • [30] The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
    Neville-Webbe, HL
    Coleman, RE
    PALLIATIVE MEDICINE, 2003, 17 (06) : 539 - 553
12345